News | April 27, 2012

New Report Shows Potential for Health Care Savings in Nuclear and Molecular Imaging

April 27, 2012 — Amidst growing concerns over healthcare costs, the Society of Nuclear Medicine (SNM) is offering a solution to help cut back on federal spending in its new report, “Imaging with CARE.” According to the report, an estimated $1.32 billion could be saved on nuclear and molecular imaging procedures over the next 10 years by taking steps to reduce the number of repeated scans due to poor quality images.

Approximately 130 million diagnostic radiology procedures—including X-rays, magnetic resonance imaging (MRI), computed tomography (CT) and nuclear medicine scans—are performed on 30 million Medicare enrollees each year. According to the Government Accountability Office, nuclear and molecular imaging scans account for $2.4 billion in costs. With an estimated four to seven percent of these procedures repeated due to poor imaging, Medicare spends $132 million in avoidable scans each year.

“Having to repeat a nuclear or molecular imaging scan because of the poor quality of the original image is something that shouldn’t happen and something that can be fixed,” said Ann Marie Alessi, BS, CNMT, NCT, RT(N), president of SNM’s Technologist Section. “By ensuring that the technologists performing these scans have appropriate training and education, Congress can ensure that most of these repeated scans are avoided.”

Each year an estimated 17 million nuclear medicine and molecular imaging procedures are performed in hospitals and medical settings across the United States. Nuclear medicine procedures use radioactive substances to visualize the molecular processes through which the body functions. This provides physicians with unique data that can help personalize treatment for heart disease, cancer, brain disorders and other diseases.

Currently only 30 states and the District of Columbia[1] have certification or licensure provisions for nuclear medicine and molecular imaging technologists that require them to be certified by a national credentialing organization. Twenty states[2] do not regulate this profession at all.

“Many state regulations also include continuing education requirements,” added Alessi. “With new technologies upon us every year, it’s critical that nuclear medicine and molecular imaging technologists are up-to-date on the techniques needed to appropriately perform the imaging scans.”

Poor quality scans can also result in misdiagnosis of disease, delays in treatment and unnecessary anxiety for the patient. If additional testing is required, patients are exposed to an increased amount of radiation. While imaging can be an invaluable tool, the procedures do carry a potential health risk, and radiation can be harmful if administered improperly.

To improve the quality of medical imaging, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging (CARE) bill has been introduced in Congress. If enacted, the bill would establish minimum education and certification standards for personnel who perform nuclear medicine and molecular imaging procedures. As a result, institutions that provide medical imaging or radiation therapy to Medicare patients would be required to employ personnel who meet or exceed the standards set by the federal government.

The CARE bill is supported by the Alliance for Quality Medical Imaging and Radiation Therapy, a group co-founded by SNM, its Technologist Section and the American Society of Radiologic Technologists in 1998. Since then, an additional 20 organizations have joined the alliance; together, the 23 groups represent more than 500,000 health care professionals. The bill currently has 89 co-sponsors, and it is expected that companion legislation will be introduced in the U.S. Senate.

For more information: www.snm.org/CARE

1 Arizona, Arkansas, California, Delaware, District of Columbia, Florida, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Mississippi, New Jersey, New Mexico, New York, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Washington, West Virginia, Wyoming.

2 Alabama, Alaska, Colorado, Connecticut, Georgia, Idaho, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, North Carolina, North Dakota, Oklahoma, South Dakota, Tennessee, Virginia, Wisconsin.

Related Content

Spectrum Dynamics Sues GE for Theft, Misappropriation of Trade Secrets and Unfair Competition
News | SPECT Imaging | December 06, 2018
Single-photon emission computed tomography (SPECT) cardiac imaging company Spectrum Dynamics filed a lawsuit Dec. 6,...
Subtle Medical Receives FDA Clearance, CE Mark for SubtlePET
Technology | PET Imaging | December 05, 2018
Subtle Medical announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SubtlePET. Subtle...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
GE Healthcare Recalls Millennium Nuclear Medicine Systems
News | Nuclear Imaging | November 15, 2018
GE Healthcare announced it is recalling its Millennium Nuclear Medicine Systems due to an incident in which the the top...
Artificial Intelligence Predicts Alzheimer's Years Before Diagnosis
News | Neuro Imaging | November 14, 2018
Artificial intelligence (AI) technology improves the ability of brain imaging to predict Alzheimer’s disease, according...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
University of Missouri Research Reactor First U.S. I-131 Supplier in 30 Years

MURR is the only supplier of I 131 in the United States and the first U.S. supplier since the 1980s. Image courtesy of University of Missouri

News | Radiopharmaceuticals and Tracers | November 13, 2018
The University of Missouri Research Reactor (MURR) recently shipped its first batch of Iodine-131 (I-131), a...
MEDraysintell Projects Increasing Mergers and Acquisitions in Nuclear Medicine
News | Nuclear Imaging | November 07, 2018
With the recent announcement by Novartis to acquire Endocyte , interest from the conventional pharmaceutical industry...
A PET/CT head and neck cancer scan.

A PET/CT head and neck cancer scan.

Feature | Nuclear Imaging | November 05, 2018 | By Sabyasachi Ghosh
“Experimental validation implemented in real-life situations and not theoretical claims exaggerating small advantages